Coronatine (COR) is composed of two structural components, coronafacic acid
(CFA) and the amino acid coronamic acid (CMA), which are joined by an amid
e bond. Monoclonal antibodies (MAbs) were prepared against COR and used in
competitive ELISAs. MAbs were secreted by hybridoma cell lines that were pr
epared from mice immunized with two different COR analogues conjugated to o
valbumin (OVA). The first hapten was prepared by reduction of the keto-oxyg
en on the cyclopentane ring of the CFA moiety of COR and subsequent reactio
n of the hydroxyl group with succinic or glutaric anhydride, which liberate
d a terminal carboxyl. This carboxyl group was coupled to carrier proteins
using active ester chemistry. For preparation of the second hapten, a CMA a
nalogue was synthesized containing a protected methylsulphydryl function at
the 2-position of the cyclopropane ring in place of the 2-ethyl group of C
MA, and the carboxylic acid was protected as a methyl ester. The hapten was
then prepared by reaction of coronafacoyl chloride with the amine function
of the CMA analogue. Following deprotection, the hapten was conjugated to
OVA and used to immunize mice. Hybridoma cell lines secreting high affinity
MAbs 11B8 (hapten 1) and 11G8 (hapten 2) were isolated. MAb 11B8 predomina
ntly recognized the coronamyl amide features of coronatine whereas 11G8 rec
ognized the coronafacoyl amide of COR. Immunoassays were developed using ea
ch of the antibodies. COR could be quantitated in the range 0.5-40 ng ml(-1
) (limit of detection 100 pg ml(-1)) and 3-100 ng ml(-1) (limit of defectio
n 800 pg ml(-1)) for 11B8 and 11G8 respectively.